Celadon Pharmaceuticals PLC (GB:CEL) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Celadon Pharmaceuticals PLC, a UK-based company specializing in cannabis-based medicines, has announced the upcoming departure of their CFO, Jonathan Turner, on December 27, 2024. The company expressed gratitude to Turner for his services and is actively seeking his successor. Celadon is known for its EU-GMP approved facility and its involvement in clinical trials for chronic pain and autism spectrum disorders treatments.
For further insights into GB:CEL stock, check out TipRanks’ Stock Analysis page.